Impact of SARS-CoV-2 Genetic Blueprints on the Oral Manifestation of COVID-19: A Case Report

Abstract

Nonsegmented positive-sense RNA enveloped RNA severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus can result in coronavirus disease 2019 (COVID-19). This virus is from β-coronaviridae family of viruses. The common signs and symptoms of COVID-19 include pyrexia, cough, dyspnea, fatigue, myalgia, cephalgia, diarrhea, and nausea. Physicians and dentists around the world could directly link the COVID-19 and oral diseases such as ageusia and anosmia. After time passes, different aspects of symptoms of the diseases have been discovered. Research suggests that the oral cavity is the most vulnerable region for the virus because of angiotensin-converting enzyme-2 (ACE2) receptor abundance in the mouth. In this case report (no. of patients = 6), we would like to report significant findings in patients who were diagnosed with COVID-19 reported to our clinic during May 2021 complaining about the oral manifestation of it such as xerostomia, gingival inflammation, and cracked teeth. All patients are younger than 40 years with no history of dental complaints and oral diseases. Fortunately, these symptoms are not life threatening and treatable/manageable by current treatment options. To date, there is no clear proof of how and via which pathway, SARS-CoV-2 genomic blueprint causes the oral manifestation of COVID-19 beside ACE2 receptor which is the only known biopathway for such incidents.

Keywords

COVID-19 / SARS-CoV-2

References

[1] Khodavirdipour A, Jabbari S, Keramat F, Alikhani MY.Concise update on genomics of COVID-19; in approach to its latest mutations, escalated contagiousness, and vaccine resistance. Glob Med Genet 2021;08(03):85-89

[2] Khodavirdipour A, Keramat F, Hashemi SH, Alikhani MY.SARSCoV- 2; from vaccine development to drug discovery and prevention guidelines. AIMS Mol Sci 2020;7(03):281-291

[3] Khodavirdipour A.Inclusion of cephalexin in COVID-19 treatment combinationsmay prevent lung involvement inmild infections: a case report with pharmacological genomics perspective. Glob Med Genet 2021;8(02):78-81

[4] Tanaka T, Narazaki M, Kishimoto T.Immunotherapeutic implications of IL-6 blockade for cytokine storm. Immunotherapy 2016;8(08):959-970

[5] Xu J, Li Y, Gan F, Du Y, Yao Y.Salivary glands: potential reservoirs for COVID-19 asymptomatic infection. J Dent Res 2020;99(08): 989

[6] Sampson V, Kamona N, Sampson A.Could there be a link between oral hygiene and the severity of SARS-CoV-2 infections? Br Dent J 2020;228(12):971-975

[7] Sinadinos A, Shelswell J.Oral ulceration and blistering in patients with COVID-19. Evid Based Dent 2020;21(02):49

[8] Chen T.Dentists are seeing an epidemic of cracked teeth. What's going on. The New York Times 2020

[9] Agyeman AA, Chin KL, Landersdorfer CB, Liew D, Ofori-Asenso R.Smell and taste dysfunction in patients with COVID-19: a systematic review and meta-analysis. Mayo Clin Proc 2020;95(08): 1621-1631

[10] Brann DH, Tsukahara T,Weinreb C, et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv 2020;6(31):eabc5801

RIGHTS & PERMISSIONS

2021 Global Medical Genetics